Impact of TP53 in MDS with isolated del(5q)

translating these findings into clinical applications will involve rigorous preclinical testing, followed by early phase clinical trials to assess the safety and effectiveness of targeting RP11-350G8.5 in patients with MM.Conflict-of-interest disclosure: M.K.

Authors

Institutions

Publication Details

Journal
Blood
Published
2024-10-17
DOI
https://doi.org/10.1182/blood.2024026010
Primary Topic
Genomic variations and chromosomal abnormalities
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of TP53 in MDS with isolated del(5q)

Lionel Adès
Blood
Genomic variations and chromosomal abnormalities
article

Impact of TP53 in MDS with isolated del(5q)

Lionel Adès
article en

Abstract

translating these findings into clinical applications will involve rigorous preclinical testing, followed by early phase clinical trials to assess the safety and effectiveness of targeting RP11-350G8.5 in patients with MM.Conflict-of-interest disclosure: M.K.

BloodVol. 144(16)
Université Paris Cité (FR), Hôpital Saint-Louis (FR), Institut de recherche Saint-Louis (FR)
Zero hunger
Openalex Percentile: Top 80%
Genomic variations and chromosomal abnormalities
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Impact of TP53 in MDS with isolated del(5q) — Lionel Adès · Blood (2024) | TGRS Research Map | TGRS